advertisement
Abstract #67257 Published in IGR 17-4
A review of selective laser trabeculoplasty in the Hong Kong Chinese population
Lee JW; Lai JSHonk Kong Medical Journal 2016; 22: 165-170
INTRODUCTION: Selective laser trabeculoplasty was first introduced to Hong Kong in 2004 for intra-ocular pressure lowering in the treatment of primary glaucoma. Since then, it has gained popularity as an alternative to anti-glaucoma medications and as a bridging therapy prior to more invasive glaucoma surgeries because of the high safety profile of the laser. METHODS: An Ovid search was performed using "selective laser trabeculoplasty" as the key word, which identified 190 unique articles; 24 reviews and/or meta-analyses were excluded. All remaining abstracts of original articles were in English. This review particularly focuses on the local population by summarising the findings from peer-reviewed publications that involved a Hong Kong Chinese population. RESULTS AND CONCLUSION: This review addresses some of the clinically relevant questions relating to selective laser trabeculoplasty including laser application, optimal energy, efficacies and success rates among different glaucoma subtypes, predictors of success, adverse effects, and intra-ocular pressure fluctuation after selective laser trabeculoplasty.
Full article
Classification:
12.4 Laser trabeculoplasty and other laser treatment of the angle (Part of: 12 Surgical treatment)
